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Characterization of Oral Cavity and Oropharyngeal Cancer in the Texas Rio Grande
Valley
Jared Sperling, M.S.1, Rachel Giese, M.D.1
Abstract
Cancers of the oral cavity (OC) and oropharynx (OP) account for 3% of cancers diagnosed in the
United States each year. A primary cause of death among the Hispanic population in the United
States is cancer, accounting for 20% of annual mortality. The Rio Grande Valley (RGV) is a
medically-underserved area of South Texas with a large Hispanic population facing health
disparities. In this study, we examine the incidence and mortality of OC and OP cancer in the
RGV. CDC population-level incidence and mortality rate per 100,000 of OC/OP cancer among
patients in the RGV counties of Hidalgo and Cameron County between 2014-2018 compared to
Texas and national incidence data was used. Starr and Willacy County data was omitted due to
case rates below the reporting threshold. Age-adjusted incidence and 95% confidence interval of
OC/OP cancer in the RGV from 2014-2018 is 7.3 [6.6, 8.0], as compared to 11.2 [11.0, 11.3] in
Texas, and 11.9 [11.8, 12.0] in the United States. Rates of OC/OP cancer among RGV Hispanics
was 6.7 [6.0, 7.5] as compared to 6.8 [6.5, 7.1] in Texas and 6.9 [6.8, 7.0] nationally. Mortality
rate in these cancers in the RGV is 1.8 [1.5, 2.2] compared to 2.5 [2.4, 2.5] in Texas. OC/OP
cancer rates are prevalent in the Rio Grande Valley but there may be an under-reporting of data.
Of note, cancer cases could not be separated by subsite (OC vs. OP) due to the method of
reporting to the database. The rising rates nationally may pose a larger problem to the RGV due
to cancer health disparities and inequities.
Introduction
Cancers of the oral cavity (OC) and oropharynx (OP) account for 3% of cancers
diagnosed in the United States each year. Though etiology may differ among subsites, the major
risk factors include tobacco and alcohol use, as well as human papillomavirus infection (HPV).
Since 1999, the age-adjusted incidence rate for oropharyngeal cancer in the United States has
increased from 10.9 per 100,000 (95% CI 10.7 – 11.0) to 11.7 per 100,000 (95% CI 11.6 – 11.8)
in 20175. This is in contrast to many other cancers with oncogenesis driven by tobacco and
alcohol use, which have largely seen a decrease in incidence due to public health measures and a
national decline in tobacco use7.
It has been suggested that the OP cancer incidence is specific to anatomic subsites driven
by HPV-oncogenesis rather than alcohol and tobacco. Although HPV vaccination rates have
risen nationally over the past 10 years, vaccination rates in Texas have been lower by about 10%
on average annually than the national average. CDC data also suggests that Hispanic men and
women have lower rates of vaccination than non-Hispanic demographics. In 2018, 36.1% of
Hispanic adults aged 18-26 received the HPV vaccination, compared to 36.7% of non-Hispanic
black adults and 42.1% of non-Hispanic white adults8.
The Rio Grande Valley is a medically underserved community and as a region has some
of the poorest health disparities in Texas and in the United States. The population is estimated to
be 1.4 million, with predominately lower education rates and lower socioeconomic status.
According to US Census Data in 2020, the percentage of uninsured population in Hidalgo and
Cameron County is 32.1% and 30.2% respectively, compared to the national average of 9.5%.

The RGV also is a predominantly Hispanic community, with greater than 90% of the population
identifying as Hispanic/Latinx. Among the Hispanic population, cancer has surpassed
cardiovascular disease as the leading cause of death1. Furthermore, it has been postulated that
health disparities and cultural factors may contribute to the mortality of cancers in the Hispanic
population1.
In Texas, the annual incidence of OC/OP cancer has remained stable. Though nonHispanic white males have the highest incidence of oropharyngeal cancer in Texas, Hispanic
males and females are also affected. To date, there has not been a publication on the incidence
and prevalence of OC and OP cancer in the South Texas, specifically the RGV Hispanic
community, in over 10 years2. Given that cancer is a leading cause of mortality in the Hispanic
population and that HPV vaccination rates are lower in the RGV, our aim in this study is to
describe the current burden of OC and OP cancers in the four-county region of the RGV.
Material and Methods
We analyzed population level data from 2014-2018, which was gathered using the Texas
Cancer Registry (TCR) and CDC-Surveillance, Epidemiology, and End Results (SEER). Data
was taken for the United States (U.S.), Texas, and the four-county region of the RGV, which
includes Hidalgo County and Cameron County. Of note, Starr County and Willacy County were
omitted due to case numbers below the threshold for reporting in TCR and SEER. The
comparable and geographically-distinct border county of El Paso County was also used to
observe any geographical differences.
Incidence rates and mortality rates for OC/OP cancers were analyzed per 100,000 people.
The incidence and mortality rates were age-adjusted to the 2000 U.S. standard population, and
stratified by gender and race/ethnicity. Race/ethnicities were standardized into the following
groups: non-Hispanic white (NHW), non-Hispanic black (NHB), Asian-Pacific Islander (API),
American Indian/Alaska Native (AI/AN), and Hispanic. Genders were standardized into male
and female gender. Cancer from the OC and OP were analyzed within the database. Of note,
cancer subsite within OC and OP could not be separated due to the nature of the data reporting.
TCR data was suppressed if fewer than 16 records were reported in a specific area-sex-race
category to ensure confidentiality and data integrity. Of note, RGV and individual county data
could not be collected for API, NHB or AI/AN due to case counts below the threshold of
reporting.
Results
In the RGV, the overall age-adjusted incidence and 95% confidence interval of OC/OP
cancer from 2014-2018 is 7.3 [6.6, 8.0], as compared to 11.2 [11.0, 11.3] in Texas, and 11.9
[11.8, 12.0] in the U.S. When stratified by race/ethnicity, rates of OC/OP cancer among RGV
Hispanics was 6.7 [6.0, 7.5] as compared to 6.8 [6.5, 7.1] in Texas and 6.9 [6.8, 7.0] nationally.
Age-adjusted incidence for RGV NHW was 10.7 [8.5, 13.4], compared to 14.1 [13.8. 14.8] in
Texas and 12.3 [12.2, 12.4] in the U.S. When stratified by gender, age-adjusted incidence for
RGV males was 10.9 [9.7, 12.3], compared to 17.2 [16.9, 17.6] in Texas and 18.0 [17.9, 18.0]
nationally. Age-adjusted incidence for RGV females was 4.3 [3.6, 5.0], compared to 5.8 [5.7,
6.0] in Texas and 6.5 [6.4, 6.5] nationally.

When looking at specific counties, the total age-adjusted incidence of OC/OP cancer was
6.8 [6.6, 7.0] in Hidalgo County, 7.8 [6.7, 9.1] in Cameron County, and 7.2 [6.4, 8.1] in El Paso
County. When stratified by race/ethnicity, the age-adjusted incidence rate was 6.6 [5.6, 7.6] for
Hispanics in Hidalgo County, 6.9 [5.6, 8.3] in Cameron County, and 6.1 [5.3, 7.1] in El Paso
County. In NHW, age-adjusted incidence rate was 9.3 [6.5, 13.2] in Hidalgo County, 12.3 [8.7,
17.3] in Cameron County, and 12.7 [10.1, 15.7] in El Paso County. When stratified by gender,
age-adjusted incidence rate was 10.6 [9.0, 12.2] in Hidalgo County, 11.9 [9.8, 14.3] in Cameron
County, and 11.7 [10.1, 13.4] in El Paso County. In females, age-adjusted incidence rate was 3.6
[2.9, 4.6] in Hidalgo County, 4.6 [3.5, 6.1] in Cameron County, and 3.8 [3.0, 4.7] in El Paso
County.
Mortality rate per 100,000 in OC/OP cancers in the RGV is 1.8 [1.5, 2.2] compared to 2.5
[2.4, 2.5] in Texas. When stratified by race/ethnicity, the mortality rate among Hispanics is 1.7
[1.3, 2.1] and 2.6 [1.5, 4.3] for NHW in the RGV.
Discussion
The RGV is a medically-underserved population facing significant barriers to health care
access and health disparities. To date, this is the first study characterizing population-level data
for OC/OP cancer in the region. Significant findings and conclusions can be drawn from the data
comparison. As a whole, the data suggests that OC/OP cancer burden is lower in the RGV as
compared to Texas and the U.S. Interestingly, this is in a sharp contrast to other cancers,
including cervical, liver and stomach cancers that are disproportionately higher in the RGV and
the Hispanic population5. As a whole, trends in differences between males and females, as well
as NHW and Hispanic demographics, followed the same trends seen in the U.S. and Texas.
The Hispanic population in the United States has a significantly lower cancer burden in
general, but many cancers disproportionately affect this population. Liver cancer has been shown
to be among the 5 most common causes of cancer mortality among the Hispanic male
population, but does not affect NHW at a significantly high rate. Similarly, stomach cancer
mortality is among the top 5 causes of cancer-related deaths among the Hispanic population, yet
does not affect NHW at such a high rate3. These two cancers may highlight the different
oncogenesis patterns that affect different populations, as these cancers may be driven by
infectious processes rather than tobacco and alcohol3. Based on this study, Hispanic RGV
OC/OP cancer burden is similar to trends of OC/OP cancer found among the Hispanic population
throughout the United States. However, the Hispanic community in Texas continues to grow
annually, indicating an increasingly large need to address this public health issue for the
population.
Regional and socioeconomic disparities may play a role in cancer incidence and
mortality. Studies have shown that rural populations have higher cancer mortality rates and
higher incidence rates for cancers with primary and secondary prevention modalities3. In our
study, this would include OP cancer, as HPV vaccination has been shown to reduce the incidence
HPV-associated OP cancer. One study by Zahnd et al. showed that rural populations had a
significantly higher rate of OP cancer than urbans4. However, the data from our study suggests
that the rural RGV community does not follow this trend.
Several factors may influence the data, which present certain limitations to this
characterization. Cancer data may not be accurately reported, which would suggest an
underrepresentation of OC/OP cancer in the RGV. Second, the data was not able to be stratified

based on subsite and anatomical location. Future studies should include this data, as it would be
able to differentiate between HPV-driven OP cancer in the base of tongue and tonsils and nonHPV associated OC cancers6.
Future directions should include further detailed analysis concerning the differences
between trends of OC and OP cancer specifically. As the Hispanic population grows, careful
consideration of overall trends paired with detailed molecular analysis and improved HPV
vaccination efforts should be prioritized to improve health outcomes for this population in the
RGV.
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